PT798309E - Agente diagnostico para a funcao glicometabolica - Google Patents

Agente diagnostico para a funcao glicometabolica

Info

Publication number
PT798309E
PT798309E PT97302141T PT97302141T PT798309E PT 798309 E PT798309 E PT 798309E PT 97302141 T PT97302141 T PT 97302141T PT 97302141 T PT97302141 T PT 97302141T PT 798309 E PT798309 E PT 798309E
Authority
PT
Portugal
Prior art keywords
diagnostic agent
glycometabolic
function
glycometabolic function
acyl
Prior art date
Application number
PT97302141T
Other languages
English (en)
Inventor
Yasuhisa Fujibayashi
Atsuo Waki
Akira Yokoyama
Original Assignee
Nihon Mediphysics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Mediphysics Co Ltd filed Critical Nihon Mediphysics Co Ltd
Publication of PT798309E publication Critical patent/PT798309E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/54—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/104998—Glucose, ketone, nitrate standard or control
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]
    • Y10T436/144444—Glucose

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT97302141T 1996-03-28 1997-03-27 Agente diagnostico para a funcao glicometabolica PT798309E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9925296 1996-03-28

Publications (1)

Publication Number Publication Date
PT798309E true PT798309E (pt) 2003-03-31

Family

ID=14242525

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97302141T PT798309E (pt) 1996-03-28 1997-03-27 Agente diagnostico para a funcao glicometabolica

Country Status (7)

Country Link
US (1) US5904915A (pt)
EP (1) EP0798309B1 (pt)
AT (1) ATE229968T1 (pt)
DE (1) DE69717895T2 (pt)
DK (1) DK0798309T3 (pt)
ES (1) ES2190797T3 (pt)
PT (1) PT798309E (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6773669B1 (en) 1995-03-10 2004-08-10 Maxcyte, Inc. Flow electroporation chamber and method
KR100430061B1 (ko) * 2000-03-21 2004-05-03 재단법인 아산사회복지재단 글루코스 유도체에 방사성 동위원소가 표지된 착화합물 및이를 생산하기 위한 조성물이 포함된 키트
US7029916B2 (en) 2001-02-21 2006-04-18 Maxcyte, Inc. Apparatus and method for flow electroporation of biological samples
EP1456345B1 (en) 2001-08-22 2016-07-20 Maxcyte, Inc. Apparatus and method for electroporation of biological samples
JP2007524649A (ja) * 2003-07-29 2007-08-30 イミューノメディクス、インコーポレイテッド フッ素化炭水化物複合体
CA2565316C (en) 2004-05-12 2017-05-30 Maxcyte, Inc. Methods and devices related to a regulated flow electroporation chamber
US8845999B2 (en) * 2005-05-23 2014-09-30 The Regents Of The University Of California Tracers for monitoring the activity of sodium/glucose cotransporters in health and disease
EP2450710B1 (en) 2006-07-14 2020-09-02 The Regents of The University of California Cancer biomarkers and methods of use thereof
US10925977B2 (en) 2006-10-05 2021-02-23 Ceil>Point, LLC Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
US20120003639A1 (en) 2010-04-27 2012-01-05 Prelude, Inc. Cancer biomarkers and methods of use thereof
WO2012174285A2 (en) * 2011-06-14 2012-12-20 The Regents Of The University Of California Inhibitor probes for imaging sodium-glucose cotransporters in health and disease
WO2016090323A1 (en) 2014-12-05 2016-06-09 Prelude, Inc. Dcis recurrence and invasive breast cancer
US20220187301A1 (en) 2018-09-14 2022-06-16 Prelude Corporation Method of selection for treatment of subjects at risk of invasive breast cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2817336C2 (de) * 1978-04-20 1984-08-23 Institute of Whole Body Metabolism, Hachioji, Tokyo Röntgenkontrastmittel und ein dieses enthaltendes diagnostisches Mittel
JP2690018B2 (ja) * 1989-07-13 1997-12-10 日本メジフィジックス株式会社 グルコサミン誘導体よりなる放射性診断剤
JP3645580B2 (ja) * 1993-10-22 2005-05-11 株式会社フジモト・ブラザーズ グルコースエステル誘導体を含有する脳代謝改善剤
JP3704173B2 (ja) * 1994-02-14 2005-10-05 日本メジフィジックス株式会社 グルコース誘導体

Also Published As

Publication number Publication date
ATE229968T1 (de) 2003-01-15
US5904915A (en) 1999-05-18
DK0798309T3 (da) 2003-03-31
DE69717895D1 (de) 2003-01-30
DE69717895T2 (de) 2003-11-13
EP0798309B1 (en) 2002-12-18
EP0798309A1 (en) 1997-10-01
ES2190797T3 (es) 2003-08-16

Similar Documents

Publication Publication Date Title
PT798309E (pt) Agente diagnostico para a funcao glicometabolica
LU88712I2 (fr) TAXOTERE-Décotaxel
ES2138691T3 (es) Procedimiento para la obtencion de derivados de n-acil-5-fluorocitidina.
ES2095884T3 (es) Agente antiviral.
NO962059L (no) Antiarytmiske benzodiazepiner
ES538757A0 (es) Procedimiento para la preparacion de 11b-aril-estradienos
DE69534287D1 (de) Bioabbaubare quaternäre Haarbehandlungsmittel
MX9102407A (es) 4 arilpiperazinas y 4-arilpiperidinas novedosas.
KR930702254A (ko) 아닐리드 유도체
ATE127791T1 (de) Quinolin-3-carboxanilid-derivate.
YU237990A (sh) Morfolinil derivati doksorubicina i postupak za njihovo dobijanje
DE3669515D1 (de) Makrozyklische antibiotika.
IT1246275B (it) Composti ammelinici e loro impiego in composizioni polimeriche autoestinguenti
NO821348L (no) 4`-halogensubstituerte sukrosederivater.
DE69936052D1 (de) N1 modifizierte glycopeptide
ES2018208B3 (es) Derivados de hidroxipirazol, procedimiento para su obtencion y su aplicacion contra microorganismos.
BG103271A (en) Derivatives of n-(benzothiazol-2-yl) piperidine-1-ethaneamines, method for their preparation and application as therapeutical means
DK0381989T3 (da) 4-epi-4-amino-anthracycliner
FI901277A0 (fi) 2,5,6,7-tetranor-4,8-inter-m-fenylen pg1z-derivativ.
FI930092A0 (fi) Indanopyrrolidinkarbamater
ATE132500T1 (de) 24r-scymnol, herstellung und verwendung
ES2043072T3 (es) Procedimiento para la diacilacion de compuestos que comprenden dos nucleos aromaticos.
KR900003196A (ko) 뉴클레오티드 유도체
EP0534567A3 (en) Stabilizers for organic materials
DE69316903D1 (de) Saintopin derivate